✦ LIBER ✦

Safety and tolerance of rHuIL-10 treatment in patients with mild/moderate active ulcerative colitis

✍ Scribed by Schreiber, S.; Fedorak, R.N.; Wild, G.; Gangl, A.; Targan, S.; Jacyna, M.; Wright, J.P.; Kilian, A.; Cohard, M.; Lebeaut, A.; Tremaine, W.J.

Book ID: 123052935
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 340 KB
Volume: 114
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(98)84395-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of safety, efficacy and p

Phase II study of safety, efficacy and pharmacokinetics of BXT-51072 in patients with mild-moderately active ulcerative colitis

✍ Hanauer, Stephen B.; Miner, Philip; Keshavarzian, Ali; Morris, Elliot; Salzberg, 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 173 KB

Efficacy and safety of adalimumab in Jap

Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitis

✍ Suzuki, Yasuo; Motoya, Satoshi; Hanai, Hiroyuki; Matsumoto, Takayuki; Hibi, Tosh 📂 Article 📅 2013 🏛 Springer Japan 🌐 English ⚖ 345 KB

Nutritional aspects in male patients wit

Nutritional aspects in male patients with ulcerative colitis in remission or mild-moderate active phase of the disease

✍ A. D'Arienzo; F. Manguso; R. Bennato; G. Vicinanza; M. Sanges; A.M. Villani; A. 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 179 KB

MMX mesalazine for the induction of remi

MMX mesalazine for the induction of remission of mild-to-moderately active ulcerative colitis: efficacy and tolerability in specific patient subpopulations

✍ G. R. LICHTENSTEIN; M. A. KAMM; W. J. SANDBORN; A. LYNE; R. E. JOSEPH 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB

A safety and efficacy study of recombina

A safety and efficacy study of recombinant human interleukin-10 (rHuIL-10) treatment in 329 patients with chronic active Crohn's disease (CACD)

✍ Schreiber, S.; Fedorak, R.N.; Nielsen, O.H.; Wild, G.; Williams, N.C.; Jacyna, M 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 178 KB

1126 Prediction of Treatment Failures in

1126 Prediction of Treatment Failures in Induction of Remission With Oral Mesalamine in Mild-to-Moderately Active Ulcerative Colitis

✍ Wolfgang Kruis; Ralph Mueller; Roland Greinwald 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 174 KB